,IL-4TLR7B

Changming Lu1, Shanrun Liu1, Min Gao2

  • 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

概括

干白素-4 (IL-4) 疗法通过重新编程B细胞发育来减少系统性红斑狼 (SLE) 中的自身抗体. 这种疗法可以抵消与SLE病变有关的托尔类受体7 (TLR7) 驱动的B细胞群.